TGRP — Tron Pharmaceuticals Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $5.52m
- $4.48m
- $1.48m
Annual cashflow statement for Tron Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | 10-K | 10-K |
Standards: | USG | USG |
Status: | Final | Final |
Net Income/Starting Line | -0.909 | -1.22 |
Depreciation | ||
Non-Cash Items | 0.015 | 0.431 |
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | -0.127 | 0.168 |
Change in Accounts Receivable | ||
Change in Inventories | ||
Change in Other Assets | ||
Change in Payable / Accrued Expenses | ||
Cash from Operating Activities | -0.805 | -0.504 |
Capital Expenditures | -0.088 | -0.019 |
Purchase of Fixed Assets | ||
Purchase / Acquisition of Intangibles | ||
Other Investing Cash Flow Items | 0.001 | 0 |
Sale of Fixed Assets | ||
Cash from Investing Activities | -0.088 | -0.019 |
Financing Cash Flow Items | 0.442 | 1.1 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | 0.478 | 1.09 |
Foreign Exchange Effects | ||
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | -0.112 | -0.253 |